These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8640970

  • 1. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Shahar E, Folsom AR, Salomaa VV, Stinson VL, McGovern PG, Shimakawa T, Chambless LE, Wu KK.
    Circulation; 1996 Jun 01; 93(11):1970-5. PubMed ID: 8640970
    [Abstract] [Full Text] [Related]

  • 2. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 01; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 3. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.
    Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE.
    Circulation; 1995 Apr 01; 91(7):1952-8. PubMed ID: 7895352
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD, LaCroix AZ, Langer RD, Trevisan M, Lewis CE, Hsia JA, Oberman A, Kotchen JM, Ridker PM.
    Circulation; 2004 Jul 20; 110(3):292-300. PubMed ID: 15238458
    [Abstract] [Full Text] [Related]

  • 5. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study.
    Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK.
    Circulation; 1995 Jan 15; 91(2):284-90. PubMed ID: 7805229
    [Abstract] [Full Text] [Related]

  • 6. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK, Mincemoyer R, Bui MN, Csako G, Pucino F, Guetta V, Waclawiw M, Cannon RO.
    N Engl J Med; 1997 Mar 06; 336(10):683-90. PubMed ID: 9041098
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.
    Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK.
    Arterioscler Thromb Vasc Biol; 2001 Apr 06; 21(4):611-7. PubMed ID: 11304480
    [Abstract] [Full Text] [Related]

  • 8. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
    DeSouza CA, Jones PP, Seals DR.
    Arterioscler Thromb Vasc Biol; 1998 Mar 06; 18(3):362-8. PubMed ID: 9514404
    [Abstract] [Full Text] [Related]

  • 9. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
    Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D.
    Metabolism; 1993 Feb 06; 42(2):236-46. PubMed ID: 8474322
    [Abstract] [Full Text] [Related]

  • 10. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.
    Al-Hamodi Z, Ismail IS, Saif-Ali R, Ahmed KA, Muniandy S.
    Cardiovasc Diabetol; 2011 Mar 18; 10():23. PubMed ID: 21414238
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
    Guler N, Burleson A, Syed D, Banos A, Hopkinson W, Hoppensteadt D, Rees H, Fareed J.
    Clin Appl Thromb Hemost; 2016 May 18; 22(4):372-6. PubMed ID: 26207021
    [Abstract] [Full Text] [Related]

  • 12. Effects of hormone replacement therapy on the circadian pattern of atherothrombotic risk factors.
    Katz RJ, Hsia J, Walker P, Jacobs H, Kessler C.
    Am J Cardiol; 1996 Oct 15; 78(8):876-80. PubMed ID: 8888658
    [Abstract] [Full Text] [Related]

  • 13. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 15; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 14. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
    Wu WD, Xu YH, Tan PY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug 15; 15(8):472-5. PubMed ID: 12919647
    [Abstract] [Full Text] [Related]

  • 15. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?
    Glueck CJ, Glueck HI, Mieczkowski L, Tracy T, Speirs J, Stroop D.
    Thromb Haemost; 1993 May 03; 69(5):460-5. PubMed ID: 8322268
    [Abstract] [Full Text] [Related]

  • 16. Development of a new test for the global fibrinolytic capacity in whole blood.
    Rijken DC, Hoegee-de Nobel E, Jie AF, Atsma DE, Schalij MJ, Nieuwenhuizen W.
    J Thromb Haemost; 2008 Jan 03; 6(1):151-7. PubMed ID: 17973653
    [Abstract] [Full Text] [Related]

  • 17. Dynamic variability of hemostatic and fibrinolytic factors in young women.
    Giardina EG, Chen HJ, Sciacca RR, Rabbani LE.
    J Clin Endocrinol Metab; 2004 Dec 03; 89(12):6179-84. PubMed ID: 15579775
    [Abstract] [Full Text] [Related]

  • 18. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.
    Diabetes; 2000 Apr 03; 49(4):633-9. PubMed ID: 10871202
    [Abstract] [Full Text] [Related]

  • 19. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.
    Eliasson M, Asplund K, Evrin PE, Lindahl B, Lundblad D.
    Metabolism; 1994 Dec 03; 43(12):1579-86. PubMed ID: 7990715
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction.
    Fernhall B, Szymanski LM, Gorman PA, Milani J, Paup DC, Kessler CM.
    Arterioscler Thromb Vasc Biol; 1997 Jun 03; 17(6):1106-13. PubMed ID: 9194761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.